Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

IBS associated with structural changes in specific brain regions

IBS associated with structural changes in specific brain regions

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Sucampo announces completion of lubiprostone phase 3 trial for CIC in Japanese patients

Sucampo announces completion of lubiprostone phase 3 trial for CIC in Japanese patients

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

Salix submits efficacy supplement for XIFAXAN NDA for Non-C IBS and IBS-related bloating

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Tioga commences dosing in Phase 3 trial of asimadoline for diarrhea-predominant irritable bowel syndrome

Canadian researchers: Probiotic found in breast milk reduces painful cramping in gut

Canadian researchers: Probiotic found in breast milk reduces painful cramping in gut

Axcan extends use of Medidata Rave as EDC and CDM system

Axcan extends use of Medidata Rave as EDC and CDM system

ICA hosts forum to improve quality of healthcare and lives of people with IC

ICA hosts forum to improve quality of healthcare and lives of people with IC

ACG announces release of new IBD podcast series

ACG announces release of new IBD podcast series

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Salix announces additional intellectual property protection for rifaximin in treatment of IBS

Salix announces additional intellectual property protection for rifaximin in treatment of IBS

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

Choir singing induces state of stimulated regeneration in IBS patients

Choir singing induces state of stimulated regeneration in IBS patients

Is gluten the latest villain in the battle for better health?

Is gluten the latest villain in the battle for better health?

Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

Rapid responders in novel behavior treatment for IBS maintain improvement at 3-month follow-up

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Sucampo presents phase 3 trial results of lubiprostone in non-cancer pain patients with OBD at DDW 2010

Sucampo reports $0.3M net loss, $14.8M total revenue for first-quarter 2010

Sucampo reports $0.3M net loss, $14.8M total revenue for first-quarter 2010